Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Drobacheff

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Acta Dermato-Venereologica|December 1, 1993
Treatment of scleroderma with oral 1,25-dihydroxyvitamin D3: evaluation of skin involvement using non-invasive techniques. Results of an open prospective trialP Humbert, J L Dupond, P Agache, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 20, 2002
Nonspecific secretory immunity in HIV-infected patients with oral candidiasisE Bard, S Laibe, S Clair, et al.
Medical Mycology|January 11, 2003
Evaluation of internal transcribed spacer region of ribosomal DNA sequence analysis for molecular characterization of Candida albicans and Candida dubliniensis isolates from HIV-infected patientsL Millon, R Piarroux, C Drobacheff, et al.
Pathologie-Biologie|November 9, 2004
[Risk factors for Abacavir-induced hypersensibility syndrome in the "real world"]C Chirouze, L Hustache-Mathieu, C Rougeot, et al.
HIV Medicine|January 7, 2010
Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?J-J Laurichesse, A Taieb, C Capoulade-Metay, et al.
European Journal of Dermatology : EJD|December 17, 1998
Porphyria cutanea tarda associated with human immunodeficiency virus infectionC Drobacheff, C Derancourt, H Van Landuyt, et al.
Presse Medicale (Paris, France : 1983)|March 26, 2004
[Predictive factors of virological response to primary antiretroviral treatment]J-F Faucher, B Challier, C Chirouze, et al.
Journal of Viral Hepatitis|July 8, 2000
Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patientsL Piroth, M Grappin, L Cuzin, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Acta Dermato-Venereologica|December 1, 1993
Treatment of scleroderma with oral 1,25-dihydroxyvitamin D3: evaluation of skin involvement using non-invasive techniques. Results of an open prospective trialP Humbert, J L Dupond, P Agache, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 20, 2002
Nonspecific secretory immunity in HIV-infected patients with oral candidiasisE Bard, S Laibe, S Clair, et al.
Medical Mycology|January 11, 2003
Evaluation of internal transcribed spacer region of ribosomal DNA sequence analysis for molecular characterization of Candida albicans and Candida dubliniensis isolates from HIV-infected patientsL Millon, R Piarroux, C Drobacheff, et al.
Pathologie-Biologie|November 9, 2004
[Risk factors for Abacavir-induced hypersensibility syndrome in the "real world"]C Chirouze, L Hustache-Mathieu, C Rougeot, et al.
HIV Medicine|January 7, 2010
Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?J-J Laurichesse, A Taieb, C Capoulade-Metay, et al.
European Journal of Dermatology : EJD|December 17, 1998
Porphyria cutanea tarda associated with human immunodeficiency virus infectionC Drobacheff, C Derancourt, H Van Landuyt, et al.
Presse Medicale (Paris, France : 1983)|March 26, 2004
[Predictive factors of virological response to primary antiretroviral treatment]J-F Faucher, B Challier, C Chirouze, et al.
Journal of Viral Hepatitis|July 8, 2000
Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patientsL Piroth, M Grappin, L Cuzin, et al.
Pageof 3